239 related articles for article (PubMed ID: 21042277)
1. CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
He Y; Northey JJ; Primeau M; Machado RD; Trembath R; Siegel PM; Lamarche-Vane N
Oncogene; 2011 Mar; 30(9):1032-45. PubMed ID: 21042277
[TBL] [Abstract][Full Text] [Related]
2. Extracellular signal-regulated kinase 1 interacts with and phosphorylates CdGAP at an important regulatory site.
Tcherkezian J; Danek EI; Jenna S; Triki I; Lamarche-Vane N
Mol Cell Biol; 2005 Aug; 25(15):6314-29. PubMed ID: 16024771
[TBL] [Abstract][Full Text] [Related]
3. A stretch of polybasic residues mediates Cdc42 GTPase-activating protein (CdGAP) binding to phosphatidylinositol 3,4,5-trisphosphate and regulates its GAP activity.
Karimzadeh F; Primeau M; Mountassif D; Rouiller I; Lamarche-Vane N
J Biol Chem; 2012 Jun; 287(23):19610-21. PubMed ID: 22518840
[TBL] [Abstract][Full Text] [Related]
4. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor.
Khoury H; Dankort DL; Sadekova S; Naujokas MA; Muller WJ; Park M
Oncogene; 2001 Feb; 20(7):788-99. PubMed ID: 11314013
[TBL] [Abstract][Full Text] [Related]
5. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
Northey JJ; Chmielecki J; Ngan E; Russo C; Annis MG; Muller WJ; Siegel PM
Mol Cell Biol; 2008 May; 28(10):3162-76. PubMed ID: 18332126
[TBL] [Abstract][Full Text] [Related]
6. Differing contributions of LIMK and ROCK to TGFβ-induced transcription, motility and invasion.
Morin P; Wickman G; Munro J; Inman GJ; Olson MF
Eur J Cell Biol; 2011 Jan; 90(1):13-25. PubMed ID: 21074289
[TBL] [Abstract][Full Text] [Related]
7. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner.
I ST; Nie Z; Stewart A; Najdovska M; Hall NE; He H; Randazzo PA; Lock P
J Cell Sci; 2004 Dec; 117(Pt 25):6071-84. PubMed ID: 15546919
[TBL] [Abstract][Full Text] [Related]
8. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition.
Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD
Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
[TBL] [Abstract][Full Text] [Related]
11. The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.
Roovers K; Wagner S; Storbeck CJ; O'Reilly P; Lo V; Northey JJ; Chmielecki J; Muller WJ; Siegel PM; Sabourin LA
Oncogene; 2009 Aug; 28(31):2839-48. PubMed ID: 19525980
[TBL] [Abstract][Full Text] [Related]
12. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
13. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
14. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
15. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
16. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
[TBL] [Abstract][Full Text] [Related]
18. Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasiveness and motility.
Brandt B; Kemming D; Packeisen J; Simon R; Helms M; Feldmann U; Matuschek A; Kersting C; Hinrichs B; Bidart JM; Bellet D; Bartkowiak K; Dankbar N; Dittmar T; Sauter G; Boecker W; Buerger H
Endocr Relat Cancer; 2005 Dec; 12(4):823-37. PubMed ID: 16322324
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
20. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.
Seton-Rogers SE; Lu Y; Hines LM; Koundinya M; LaBaer J; Muthuswamy SK; Brugge JS
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1257-62. PubMed ID: 14739340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
